Want to see SOLV full AI Analyst Report?
Net Sales by Segment
Lists revenue for each business unit so investors can see the relative size, growth, and contribution of core operations. Tracking segment sales over time helps assess diversification, market share gains or losses, and which segments will drive future company performance.Core franchises—MedSurg, Dental and Health Information Systems—are delivering steady organic momentum that underpins management’s margin‑expansion and EPS targets. The disappearance of Purification & Filtration reflects a completed divestiture, improving revenue mix but contributing to reported sales drag. Large swings in “Other” look like timing, acquisition (Acera) and ERP‑related order phasing rather than sustainable growth, so expect quarter‑to‑quarter noise. Focus on underlying organic trends plus the $500M Transform savings and SKU rationalization for durable margin upside, while ERP cutover and remaining TSAs create near‑term modeling risk.
Date | Other | Medsurg | Dental Solutions | Health Information Systems | Purification & Filtration |
|---|---|---|---|---|---|
Jun 30, 2026 | $87.00M | $1.37B | $396.00M | $354.00M | $0.00 |
Mar 31, 2026 | $76.00M | $1.23B | $354.00M | $342.00M | $0.00 |
Dec 31, 2025 | $72.00M | $1.24B | $343.00M | $348.00M | $0.00 |
Sep 30, 2025 | $77.00M | $1.21B | $340.00M | $345.00M | $128.00M |
Jun 30, 2025 | $15.00M | $1.22B | $338.00M | $339.00M | $252.00M |
Mar 31, 2025 | $13.00M | $1.16B | $328.00M | $329.00M | $242.00M |
Dec 31, 2024 | $14.00M | $1.17B | $316.00M | $335.00M | $235.00M |
Sep 30, 2024 | $23.00M | $1.18B | $313.00M | $326.00M | $238.00M |
Jun 30, 2024 | $22.00M | $1.16B | $331.00M | $328.00M | $238.00M |
Mar 31, 2024 | $0.00 | $1.12B | $335.00M | $317.00M | $245.00M |